SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-14-000013
Filing Date
2014-10-30
Accepted
2014-10-30 15:40:57
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcrx-9302014x10xq.htm 10-Q 937386
2 EXHIBIT 10.1 pcrx-93014xex101.htm EX-10.1 100136
3 EXHIBIT 31.1 pcrx-93014xex311.htm EX-31.1 14765
4 EXHIBIT 31.2 pcrx-93014xex312.htm EX-31.2 14767
5 EXHIBIT 32.1 pcrx-93014xex321.htm EX-32.1 5610
6 EXHIBIT 32.2 pcrx-93014xex322.htm EX-32.2 5513
  Complete submission text file 0001396814-14-000013.txt   6840536

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pcrx-20140930.xml EX-101.INS 1082396
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20140930.xsd EX-101.SCH 45103
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20140930_cal.xml EX-101.CAL 76490
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20140930_def.xml EX-101.DEF 173464
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20140930_lab.xml EX-101.LAB 582456
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20140930_pre.xml EX-101.PRE 307602
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 141183143
SIC: 2834 Pharmaceutical Preparations